Home » CAMBODIAN VENTURES REACHES AGREEMENT TO ACQUIRE INTEREST IN COMPANY SPECIALIZING IN HUMAN AVIAN INFLUENZA SOLUTIONS
CAMBODIAN VENTURES REACHES AGREEMENT TO ACQUIRE INTEREST IN COMPANY SPECIALIZING IN HUMAN AVIAN INFLUENZA SOLUTIONS
Cambodian Ventures Limited (OTC: CMBV), announced today that it has reached a definitive agreement to acquire up to 25% of Montreal based Canadian Bio Med Systems Inc. CBMS will focus on providing education, preventive and protective products, as well as anti-influenza medications. Canadian Bio Med Systems (CBMS) is a company recently formed to provide solutions to the general public in dealing with the containment of the deadly avian influenza A virus (H5N1), also known as "Bird Flu," among humans.
Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=100171)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May